FluoGuide A/S FLUO
Updated: 9 Aug 2026
No signal published yet
We already track FluoGuide and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow FluoGuide A/S? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow FluoGuide free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On June 29, 2026, FluoGuide announced positive results from the first part of its Phase 2 trial evaluating FG001 for surgical guidance in oral head and neck cancer. Subsequently, on July 1, 2026, the company issued an update on its 2026 outlook and operational progress.
What Firelda Watch includes for FluoGuide A/S
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow FluoGuide A/S? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow FluoGuide free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more